Malnutrition Screening and Assessment in the Cancer Care Ambulatory Setting: Mortality Predictability and Validity of the Patient-Generated Subjective Global Assessment Short form (PG-SGA SF) and the GLIM Criteria

Lynette M De Groot, Gahee Lee, Antoinette Ackerie, Barbara S van der Meij, Lynette M De Groot, Gahee Lee, Antoinette Ackerie, Barbara S van der Meij

Abstract

Background: A valid malnutrition screening tool (MST) is essential to provide timely nutrition support in ambulatory cancer care settings. The aim of this study is to investigate the validity of the Patient-Generated Subjective Global Assessment Short Form (PG-SGA SF) and the new Global Leadership Initiative on Malnutrition (GLIM) criteria as compared to the reference standard, the Patient-Generated Subjective Global Assessment (PG-SGA).

Methods: Cross-sectional observational study including 246 adult ambulatory patients with cancer receiving in-chair intravenous treatment at a cancer care centre in Australia. Anthropometrics, handgrip strength and patient descriptive data were assessed. Nutritional risk was identified using MST and PG-SGA SF, nutritional status using PG-SGA and GLIM. Sensitivity (Se), specificity (Sp), positive and negative predictive values and kappa (k) were analysed. Associations between malnutrition and 1-year mortality were investigated by Cox survival analyses.

Results: A PG-SGA SF cut-off score ≥5 had the highest agreement when compared with the PG-SGA (Se: 89%, Sp: 80%, k = 0.49, moderate agreement). Malnutrition risk (PG-SGA SF ≥ 5) was 31% vs. 24% (MST). For malnutrition according to GLIM, the Se was 76% and Sp was 73% (k = 0.32, fair agreement) when compared to PG-SGA. The addition of handgrip strength to PG-SGA SF or GLIM did not improve Se, Sp or agreement. Of 100 patients who provided feedback, 97% of patients found the PG-SGA SF questions easy to understand, and 81% reported that it did not take too long to complete. PG-SGA SF ≥ 5 and severe malnutrition by GLIM were associated with 1-year mortality risk.

Conclusions: The PG-SGA SF and GLIM criteria are accurate, sensitive and specific malnutrition screening and assessment tools in the ambulatory cancer care setting. The addition of handgrip strength tests did not improve the recognition of malnutrition or mortality risk.

Keywords: cancer; handgrip strength; malnutrition; nutrition assessment.

Conflict of interest statement

The authors declare no conflicts of interest.

References

    1. Kumar A., Saxena M., Hammond N., Taylor C., Thompson K., Grattan S. Near Two-fold Rise in ICD-coded Sepsis-related Hospital Admissions in Australia: An Australian Institute of Health and Welfare Database Analysis (2011–2016) Aust. Crit. Care. 2019;32:S7. doi: 10.1016/j.aucc.2018.11.025.
    1. Hébuterne X., Lemarié E., Michallet M., De Montreuil C.B., Schneider S.M., Goldwasser F. Prevalence of Malnutrition and Current Use of Nutrition Support in Patients with Cancer. J. Parenter. Enter. Nutr. 2014;38:196–204. doi: 10.1177/0148607113502674.
    1. Arends J., Baracos V., Bertz H., Bozzetti F., Calder P.C., Deutz N.E.P., Erickson N., Laviano A., Lisanti M., Lobo D.N., et al. ESPEN expert group recommendations for action against cancer-related malnutrition. Clin. Nutr. 2017;36:1187–1196. doi: 10.1016/j.clnu.2017.06.017.
    1. Andreyev H.J.N., Norman A.R., Oates J., Cunningham D. Why do patients with weight loss have a worse outcome when undergoing chemotherapy for gastrointestinal malignancies? Eur. J. Cancer. 1998;34:503–509. doi: 10.1016/S0959-8049(97)10090-9.
    1. Persson C., Glimelius B. The relevance of weight loss for survival and quality of life in patients with advanced gastrointestinal cancer treated with palliative chemotherapy. Anticancer. Res. 2003;22:3661–3668.
    1. Lim S.L., Ong K.C.B., Chan Y.H., Loke W.C., Ferguson M., Daniels L. Malnutrition and its impact on cost of hospitalization, length of stay, readmission and 3-year mortality. Clin. Nutr. 2012;31:345–350. doi: 10.1016/j.clnu.2011.11.001.
    1. DeWys W.D., Begg C., Lavin P.T., Band P.R., Bennett J.M., Bertino J.R., Cohen M.H., Douglass H.O., Engstrom P.F., Ezdinli E.Z., et al. Prognostic effect of weight loss prior tochemotherapy in cancer patients. Am. J. Med. 1980;69:491–497. doi: 10.1016/S0149-2918(05)80001-3.
    1. Datema F.R., Ferrier M.B., De Jong R.J.B. Impact of severe malnutrition on short-term mortality and overall survival in head and neck cancer. Oral Oncol. 2011;47:910–914. doi: 10.1016/j.oraloncology.2011.06.510.
    1. Berg M.G.A.V.D., Rasmussen-Conrad E.L., Wei K.H., Lintz-Luidens H., Kaanders J.H.A.M., Merkx M. Comparison of the effect of individual dietary counselling and of standard nutritional care on weight loss in patients with head and neck cancer undergoing radiotherapy. Br. J. Nutr. 2010;104:872–877. doi: 10.1017/S0007114510001315.
    1. Schmidt K.N., Olson K., Kubrak C., Parliament M., Ghosh S. Validation of the Head and Neck Patient Symptom Checklist as a nutrition impact symptom assessment tool for head and neck cancer patients. Support. Care Cancer. 2012;21:27–34. doi: 10.1007/s00520-012-1483-y.
    1. Um M.H., Choi M.Y., Lee S.M., Lee I.-J., Lee C.G., Park Y.K. Intensive nutritional counseling improves PG-SGA scores and nutritional symptoms during and after radiotherapy in Korean cancer patients. Support. Care Cancer. 2014;22:2997–3005. doi: 10.1007/s00520-014-2304-2.
    1. Arends J., Bachmann P., Baracos V., Barthelemy N., Bertz H., Bozzetti F., Fearon K., Hütterer E., Isenring E., Kaasa S., et al. ESPEN guidelines on nutrition in cancer patients. Clin. Nutr. 2017;36:11–48. doi: 10.1016/j.clnu.2016.07.015.
    1. Kubrak C., Jensen L. Critical Evaluation of Nutrition Screening Tools Recommended for Oncology Patients. Cancer Nurs. 2007;30:E1–E6. doi: 10.1097/01.NCC.0000290818.45066.00.
    1. Jager-Wittenaar H., Ottery F.D. Assessing nutritional status in cancer. Curr. Opin. Clin. Nutr. Metab. Care. 2017;20:322–329. doi: 10.1097/MCO.0000000000000389.
    1. Gabrielson D.K., Scaffidi D., Leung E., Stoyanoff L., Robinson J., Nisenbaum R., Brezden-Masley C., Darling P.B. Use of an Abridged Scored Patient-Generated Subjective Global Assessment (abPG-SGA) as a Nutritional Screening Tool for Cancer Patients in an Outpatient Setting. Nutr. Cancer. 2013;65:234–239. doi: 10.1080/01635581.2013.755554.
    1. Abbott J., Teleni L., McKavanagh D., Watson J., McCarthy A.L., Isenring E. Patient-Generated Subjective Global Assessment Short Form (PG-SGA SF) is a valid screening tool in chemotherapy outpatients. Support. Care Cancer. 2016;24:3883–3887. doi: 10.1007/s00520-016-3196-0.
    1. Ottery F.D., PG-SGA© PG-SGA/Pt-Global Platform. [(accessed on 8 July 2020)]; Available online:
    1. Di Bella A., Blake C., Young A., Pelecanos A., Brown T. Reliability of Patient-Led Screening with the Malnutrition Screening Tool: Agreement between Patient and Health Care Professional Scores in the Cancer Care Ambulatory Setting. J. Acad. Nutr. Diet. 2018;118:1065–1071. doi: 10.1016/j.jand.2017.11.023.
    1. Norman K., Stobäus N., Smoliner C., Zocher D., Scheufele R., Valentini L., Lochs H., Pirlich M. Determinants of hand grip strength, knee extension strength and functional status in cancer patients. Clin. Nutr. 2010;29:586–591. doi: 10.1016/j.clnu.2010.02.007.
    1. Versteeg K.S., Blauwhoff-Buskermolen S., Buffart L., De Van Der Schueren M.A., Langius J.A.E., Verheul H.M.W., Maier A.B., Konings I.R. Higher Muscle Strength Is Associated with Prolonged Survival in Older Patients with Advanced Cancer. Oncologist. 2017;23:580–585. doi: 10.1634/theoncologist.2017-0193.
    1. Norman K., Wirth R., Neubauer M., Eckardt R., Stobäus N. The Bioimpedance Phase Angle Predicts Low Muscle Strength, Impaired Quality of Life, and Increased Mortality in Old Patients with Cancer. J. Am. Med. Dir. Assoc. 2015;16:173.e17–173.e22. doi: 10.1016/j.jamda.2014.10.024.
    1. Cederholm T., Jensen G., Correia M., Gonzalez M., Fukushima R., Higashiguchi T., Baptista G., Barazzoni R., Blaauw R., Coats A., et al. GLIM criteria for the diagnosis of malnutrition—A consensus report from the global clinical nutrition community. Clin. Nutr. 2019;38:1–9. doi: 10.1016/j.clnu.2018.08.002.
    1. Isenring E., Cross G., Daniels L., Kellett E., Koczwara B. Validity of the malnutrition screening tool as an effective predictor of nutritional risk in oncology outpatients receiving chemotherapy. Support. Care Cancer. 2006;14:1152–1156. doi: 10.1007/s00520-006-0070-5.
    1. Dodds R.M., Syddall H.E., Cooper R., Benzeval M., Deary I.J., Dennison E.M., Der G., Gale C.R., Inskip H., Jagger C., et al. Grip Strength across the Life Course: Normative Data from Twelve British Studies. PLoS ONE. 2014;9:e113637. doi: 10.1371/journal.pone.0113637.
    1. Planas M., Álvarez-Hernández J., León-Sanz M., Celaya-Pérez S., Araujo K., De Lorenzo A.G., Researchers on behalf of the PREDyCES® Prevalence of hospital malnutrition in cancer patients: A sub-analysis of the PREDyCES® study. Support. Care Cancer. 2016;24:429–435. doi: 10.1007/s00520-015-2813-7.
    1. Onesti J.K., Guttridge D.C. Inflammation Based Regulation of Cancer Cachexia. BioMed Res. Int. 2014;2014:1–7. doi: 10.1155/2014/168407.
    1. Raslan M., Gonzalez M.C., Dias M.C.G., Nascimento M., Castro M., Marques P., Segatto S., Torrinhas R.S., Cecconello I., Waitzberg D.L. Comparison of nutritional risk screening tools for predicting clinical outcomes in hospitalized patients. Nutrition. 2010;26:721–726. doi: 10.1016/j.nut.2009.07.010.
    1. Viera A.J., Garrett J.M. Understanding interobserver agreement: The kappa statistic. Fam. Med. 2005;37:360–363.
    1. McHugh M.L. Interrater reliability: The kappa statistic. Biochem. Medica. 2012:276–282. doi: 10.11613/BM.2012.031.
    1. Campbell K.L., Bauer J.D., Ikehiro A., Johnson D.W. Role of Nutrition Impact Symptoms in Predicting Nutritional Status and Clinical Outcome in Hemodialysis Patients: A Potential Screening Tool. J. Ren. Nutr. 2013;23:302–307. doi: 10.1053/j.jrn.2012.07.001.
    1. Mendonsa R.D., Appaya P. Psychiatric morbidity in outpatients of gynecological oncology clinic in a tertiary care hospital. Indian J. Psychiatry. 2010;52:327–332. doi: 10.4103/0019-5545.74307.
    1. Nho J.-H., Kim S.R., Kwon Y.S. Depression and appetite: Predictors of malnutrition in gynecologic cancer. Support. Care Cancer. 2014;22:3081–3088. doi: 10.1007/s00520-014-2340-y.
    1. Shaw C., Fleuret C., Pickard J.M., Mohammed K., Black G., Wedlake L. Comparison of a novel, simple nutrition screening tool for adult oncology inpatients and the Malnutrition Screening Tool (MST) against the Patient-Generated Subjective Global Assessment (PG-SGA) Support. Care Cancer. 2014;23:47–54. doi: 10.1007/s00520-014-2319-8.
    1. Bauer J.D., Capra S.M., Ferguson M. Use of the scored Patient-Generated Subjective Global Assessment (PG-SGA) as a nutrition assessment tool in patients with cancer. Eur. J. Clin. Nutr. 2002;56:779–785. doi: 10.1038/sj.ejcn.1601412.
    1. Read J.A., Crockett N., Volker D.H., MacLennan P., Choy S.T.B., Beale P., Clarke S.J. Nutritional Assessment in Cancer: Comparing the Mini-Nutritional Assessment (MNA) With the Scored Patient-Generated Subjective Global Assessment (PGSGA) Nutr. Cancer. 2005;53:51–56. doi: 10.1207/s15327914nc5301_6.
    1. Norman K., Schütz T., Kemps M., Lübke H.J., Lochs H., Pirlich M. The Subjective Global Assessment reliably identifies malnutrition-related muscle dysfunction. Clin. Nutr. 2005;24:143–150. doi: 10.1016/j.clnu.2004.08.007.
    1. Ryan A.M., Power D.G., Daly L.E., Cushen S.J., Bhuachalla Ēadaoin N., Prado C.M. Cancer-associated malnutrition, cachexia and sarcopenia: The skeleton in the hospital closet 40 years later. Proc. Nutr. Soc. 2016;75:199–211. doi: 10.1017/S002966511500419X.
    1. Contreras-Bolívar V., Sánchez-Torralvo F.J., Ruiz-Vico M., González-Almendros I., Barrios M., Padín S., Alba E., Olveira-Fuster A.G., Bolívar C., Torralvo S., et al. GLIM Criteria Using Hand Grip Strength Adequately Predict Six-Month Mortality in Cancer Inpatients. Nutrients. 2019;11:2043. doi: 10.3390/nu11092043.
    1. Yilmaz M., Atilla F.D., Sahin F., Saydam G. The effect of malnutrition on mortality in hospitalized patients with hematologic malignancy. Support. Care Cancer. 2019;28:1441–1448. doi: 10.1007/s00520-019-04952-5.

Source: PubMed

Sponsorer och medarbetare

Medicinska tillstånd

Läkemedelsinterventioner

3
Prenumerera